Dolby Laboratories (DLB)
Days of sales outstanding (DSO)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 2.60 | 2.98 | 2.93 | 3.00 | 3.15 | 3.15 | 3.19 | 3.08 | 3.58 | — | — | 3.59 | 3.88 | 3.29 | 3.06 | 2.99 | 4.79 | 3.67 | 3.44 | 6.45 | |
| DSO | days | 140.20 | 122.54 | 124.58 | 121.48 | 115.88 | 115.69 | 114.56 | 118.46 | 102.03 | — | — | 101.76 | 94.04 | 110.87 | 119.44 | 121.90 | 76.17 | 99.54 | 106.17 | 56.63 |
September 30, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 2.60
= 140.20
Based on the data provided, Dolby Laboratories' Days of Sales Outstanding (DSO) fluctuated over the past quarters. DSO can be calculated by dividing accounts receivable by daily sales, then multiplying the result by the number of days in the period.
In the most recent period ending September 30, 2024, the DSO was 140.20 days, reflecting an increase compared to the previous quarter's DSO of 122.54 days. This indicates that Dolby Labs took longer to collect receivables from customers in the latest quarter.
Looking back over the past few quarters, there has been a general upward trend in DSO since September 2023, where the DSO was 115.88 days. The increase in DSO could suggest that Dolby Labs may be experiencing challenges in collecting receivables efficiently, potentially impacting its cash flow and liquidity position.
It is also noteworthy that there are some missing data points for DSO in the financial statements, particularly in the most recent and some previous quarters. This could be due to various reasons such as changes in reporting practices or other internal factors affecting data availability.
Overall, monitoring and effectively managing DSO is crucial for Dolby Laboratories to ensure timely collection of receivables and maintain a healthy cash conversion cycle, which is essential for sustaining operational activities and funding future growth initiatives.
Peer comparison
Sep 30, 2024